Effects of glucagon‐like peptide‐1 receptor agonists on cardiovascular and renal outcomes: A <scp>meta‐analysis</scp> and <scp>meta‐regression</scp> analysis-Reference-Cited by-同舟云学术

Effects of glucagon‐like peptide‐1 receptor agonists on cardiovascular and renal outcomes: A meta‐analysis and meta‐regression analysis

Published:2022-02-21 Issue:6 Volume:24 Page:1029-1037
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obesity Metabolism

Author:

Yoshiji Satoshi¹²³⁴^ORCID,Minamino Hiroto¹⁴^ORCID,Tanaka Daisuke¹,Yamane Shunsuke¹,Harada Norio¹^ORCID,Inagaki Nobuya¹^ORCID

Affiliation:

1. Department of Diabetes, Endocrinology and Nutrition Graduate School of Medicine, Kyoto University Kyoto Japan

2. Department of Human Genetics McGill University Montréal Québec Canada

3. Kyoto‐McGill International Collaborative Program in Genomic Medicine Graduate School of Medicine, Kyoto University Kyoto Japan

4. Japan Society for the Promotion of Science Tokyo Japan

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14666

Reference41 articles.

1. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Buse JB;Diabetes Care.,2018

2. Understanding the place for GLP‐1RA therapy: Translating guidelines for treatment of type 2 diabetes into everyday clinical practice and patient selection

3. Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

4. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

5. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care;Diabetologia;2024-08-23

2. Potential kidney protective effects of glucagon‐like peptide‐1 receptor agonists;Nephrology;2024-06-20

3. Semaglutide Effects on Metabolic Outcomes in Diabetes Mellitus Patients — Real World Study;Diabetes, Metabolic Syndrome and Obesity;2024-04

4. Renal effects of GLP-1 receptor agonists and tirzepatide in individuals with type 2 diabetes: seeds of a promising future;Endocrine;2024-03-12

5. Mediators of Cardiovascular and Renal Outcomes: How Do Novel Diabetes Medications Work?;Journal of the American Heart Association;2024-02-20